Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels.

[1]  P. Stroebel,et al.  The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors. , 2014, Urologic oncology.

[2]  D. Jackson,et al.  Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome. , 2013, Urologic oncology.

[3]  G. Cassali,et al.  Assessment of vascular invasion in gastric cancer: a comparative study. , 2013, World journal of gastroenterology.

[4]  M. Detmar,et al.  Interaction of tumor cells and lymphatic vessels in cancer progression , 2012, Oncogene.

[5]  S. Fosså,et al.  Sequelae of treatment in long-term survivors of testis cancer. , 2011, European urology.

[6]  A. Horwich,et al.  EAU guidelines on testicular cancer: 2011 update. , 2011, European urology.

[7]  Dai Fukumura,et al.  Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre‐Clinical Models , 2010, Microcirculation.

[8]  R. Bremnes,et al.  Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Alken,et al.  Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis , 2009, BJU international.

[10]  S. Stacker,et al.  Molecular Control of Lymphatic Metastasis , 2008, Annals of the New York Academy of Sciences.

[11]  I. Ellis,et al.  Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences , 2007, The American journal of surgical pathology.

[12]  S. Fox,et al.  First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours , 2006, British Journal of Cancer.

[13]  A. Bleyer,et al.  Cancer in 15- to 29-year-olds by primary site. , 2006, The oncologist.

[14]  A. Harris,et al.  A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity , 2005, British Journal of Cancer.

[15]  P. Alken,et al.  Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). , 2004, The Journal of urology.

[16]  M. Karkkainen,et al.  Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. , 2004, Trends in immunology.

[17]  Rakesh K. Jain,et al.  Pathology: Cancer cells compress intratumour vessels , 2004, Nature.

[18]  J. Habbema,et al.  Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Albers,et al.  Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. , 2003, European urology.

[20]  R. Fimmers,et al.  Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Akiba,et al.  Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease , 1999, Cancer.

[22]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[23]  D. Ondruš,et al.  Prognostic Factors in Clinical Stage I Nonseminomatous GermCell Testicular Tumors: Rationale for Different Risk-Adapted Treatment , 1998, European Urology.

[24]  Lee,et al.  Vascular density does not predict future metastatic disease in clinical stage 1 non‐seminomatous germ cell tumours of the testis , 1998, Histopathology.

[25]  G. Sledge,et al.  Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. , 1994, Cancer research.

[26]  S. Brooks,et al.  Molecular interactions in cancer cell metastasis. , 2010, Acta histochemica.

[27]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.